Addus HomeCare (NASDAQ:ADUS) EVP Roberton James Stevenson Sells 567 Shares

Addus HomeCare Corporation (NASDAQ:ADUS) EVP Roberton James Stevenson sold 567 shares of the company’s stock in a transaction on Tuesday, February 24th. The stock was sold at an average price of $107.35, for a total transaction of $60,867.45. Following the transaction, the executive vice president directly owned 14,314 shares in the company, valued at approximately $1,536,607.90. This trade represents a 3.81% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Roberton James Stevenson also recently made the following trade(s):

• On Wednesday, February 25th, Roberton James Stevenson sold 284 shares of Addus HomeCare stock. The stock was sold at an average price of $105.36, for a total transaction of $29,922.24.

Addus HomeCare Trading Down 0.7%

Shares of ADUS opened at $103.29 on Friday. Addus HomeCare Corporation has a twelve month low of $88.96 and a twelve month high of $124.43. The company has a current ratio of 1.80, a quick ratio of 1.66 and a debt-to-equity ratio of 0.11. The firm has a market capitalization of $1.91 billion, a P/E ratio of 19.83, a PEG ratio of 1.49 and a beta of 0.91. The firm’s 50-day moving average is $109.41 and its two-hundred day moving average is $113.01.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the company. Royal Bank of Canada lifted its holdings in Addus HomeCare by 24.3% in the 1st quarter. Royal Bank of Canada now owns 6,899 shares of the company’s stock valued at $682,000 after purchasing an additional 1,347 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in shares of Addus HomeCare by 4.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 10,374 shares of the company’s stock worth $1,026,000 after buying an additional 459 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its position in shares of Addus HomeCare by 6.1% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 51,679 shares of the company’s stock valued at $5,111,000 after buying an additional 2,952 shares during the last quarter. Jane Street Group LLC raised its position in shares of Addus HomeCare by 387.6% in the first quarter. Jane Street Group LLC now owns 11,045 shares of the company’s stock valued at $1,092,000 after buying an additional 8,780 shares during the last quarter. Finally, Intech Investment Management LLC lifted its stake in shares of Addus HomeCare by 44.7% during the first quarter. Intech Investment Management LLC now owns 14,362 shares of the company’s stock valued at $1,420,000 after buying an additional 4,439 shares during the period. Institutional investors and hedge funds own 95.35% of the company’s stock.

Wall Street Analyst Weigh In

ADUS has been the subject of several research reports. BMO Capital Markets assumed coverage on Addus HomeCare in a report on Thursday, November 13th. They set a “market perform” rating and a $120.00 price objective for the company. Stephens cut their price target on Addus HomeCare from $140.00 to $135.00 and set an “overweight” rating for the company in a research note on Wednesday. Barclays decreased their price objective on shares of Addus HomeCare from $117.00 to $112.00 and set an “underweight” rating on the stock in a research report on Tuesday. Weiss Ratings restated a “hold (c+)” rating on shares of Addus HomeCare in a report on Wednesday, January 21st. Finally, TD Cowen restated a “buy” rating on shares of Addus HomeCare in a research report on Wednesday, November 5th. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, Addus HomeCare has a consensus rating of “Moderate Buy” and a consensus price target of $134.33.

More Addus HomeCare News

Here are the key news stories impacting Addus HomeCare this week:

• Positive Sentiment: Stephens retained an “Overweight” rating on ADUS and set a $135 price target (trimmed from $140), keeping a constructive analyst opinion that supports medium-term upside. Read More.
• Positive Sentiment: Large institutional investors increased positions in recent quarters (Capital Research, Vanguard, Wasatch, State Street and others), signaling continued institutional confidence and buying power underneath the stock. Read More.
• Neutral Sentiment: Short-interest reporting is inconsistent across feeds (some entries show 0 shares, others show a material rise), creating data noise — investors should confirm with official FINRA/exchange data before sizing positions. Read More.
• Negative Sentiment: Insiders sold multiple tranches of stock on Feb. 24–25: CEO R. Dirk Allison sold several thousand shares (~7,300 across filings) and numerous EVPs also liquidated positions — concentrated insider selling often weighs on sentiment and can pressure the share price. Read More.
• Negative Sentiment: Reported short interest increased materially in February to roughly 1.15M shares (~6.5% of float, ~4.6 days to cover in mid-February) — a larger short book can amplify downside on negative headlines and increase volatility. Read More.
• Negative Sentiment: Media picked up a “pessimistic forecast” narrative tied to Stephens’ shorter-term expectations after the PT cut, which can reinforce selling pressure despite the retained Overweight rating. Read More.

About Addus HomeCare

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.